Research Analysts’ Upgrades for November 8th (AFYA, AMD, AMTM, ASND, ATRO, BMRN, CI, CMPS, DAVE, DLX)

Research Analysts’ upgrades for Sunday, November 8th:

Afya (NASDAQ:AFYA) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Advanced Micro Devices (NASDAQ:AMD) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Amentum (NYSE:AMTM) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Astronics (NASDAQ:ATRO) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Cigna Group (NYSE:CI) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Compass Pathways (NASDAQ:CMPS) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Dave (NASDAQ:DAVE) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Deluxe (NYSE:DLX) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Edwards Lifesciences (NYSE:EW) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Federal Realty Investment Trust (NYSE:FRT) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Genius Sports (NYSE:GENI) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

JIADE (NASDAQ:JDZG) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Jones Lang LaSalle (NYSE:JLL) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Alliant Energy (NASDAQ:LNT) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Lexicon Pharmaceuticals (NASDAQ:LXRX) was upgraded by analysts at Wall Street Zen from a strong sell rating to a hold rating.

MediaAlpha (NYSE:MAX) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Medtronic (NYSE:MDT) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Norwegian Cruise Line (NYSE:NCLH) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Olin (NYSE:OLN) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Precigen (NASDAQ:PGEN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Progyny (NASDAQ:PGNY) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Portillo’s (NASDAQ:PTLO) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

QuinStreet (NASDAQ:QNST) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Schneider National (NYSE:SNDR) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Vertiv (NYSE:VRT) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

WEC Energy Group (NYSE:WEC) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

WEX (NYSE:WEX) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

WhiteHawk Income (NYSE:WHK) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Westlake Chemical Partners (NYSE:WLKP) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Xcel Energy (NASDAQ:XEL) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.